Christopher Cabell

Insider Reports History

Location
San Diego, CA
Signature
/s/ Mark Iwicki, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Cabell:

Form 4 holding CMO & Head of R&D

Zura Bio Ltd

Security class
Class A Ordinary Shares
Shares / value
162,060
Estimated value
$648,240
Report date
18 May 2023
Price
$4.00
Ownership
Direct
Form 4 holding Director

Pulmatrix, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
1,700
Estimated value
Report date
26 Jan 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Christopher Cabell

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .